The triterpene echinocystic acid and its 3-O-glucoside derivative are revealed as potent and selective glucocorticoid receptor agonists.
Glucocorticoids are steroid hormones widely used to control many inflammatory conditions. These effects are primarily attributed to glucocorticoid receptor transrepressional activities but with concomitant receptor transactivation associated with considerable side effects. Accordingly, there is an immediate need for selective glucocorticoid receptor agonists able to dissociate transactivation from transrepression. Triterpenoids have structural similarities with glucocorticoids and exhibit anti-inflammatory and apoptotic activities via mechanisms that are not well-defined. In this study, we examined whether echinocystic acid and its 3-O-glucoside derivative act, at least in part, through the regulation of glucocorticoid receptor and whether they can constitute selective receptor activators. We showed that echinocystic acid and its glucoside induced glucocorticoid receptor nuclear translocation by 75% and 55%. They suppressed the nuclear factor-kappa beta transcriptional activity by 20% and 70%, respectively, whereas they have no glucocorticoid receptor transactivation capability and stimulatory effect on the expression of the phosphoenolopyruvate carboxykinase target gene in HeLa cells. Interestingly, their suppressive effect is diminished in glucocorticoid receptor low level COS-7 cells, verifying the receptor involvement in this process. Induced fit docking calculations predicted favorable binding in the ligand binding domain and structural characteristics which can be considered consistent with the experimental observations. Further, glucocorticoids exert apoptotic activities; we have demonstrated here that the echinocystic acids in combination with the synthetic glucocorticoid, dexamethasone, induce apoptosis. Taken together, our results indicate that echinocystic acids are potent glucocorticoid receptor regulators with selective transrepressional activities (dissociated from transactivation), highlighting the potential of echinocystic acid derivatives as more promising treatments for inflammatory conditions.
Department of Biochemistry and Biotechnology, University of Thessaly, Larissa, Greece.
Demetra
D
Georgatza
Department of Biochemistry and Biotechnology, University of Thessaly, Larissa, Greece.
Vyron A
VA
Gorgogietas
Department of Biochemistry and Biotechnology, University of Thessaly, Larissa, Greece.
Paraskevi
P
Kylindri
Department of Biochemistry and Biotechnology, University of Thessaly, Larissa, Greece.
Maria Ch
MC
Charalambous
Department of Biochemistry and Biotechnology, University of Thessaly, Larissa, Greece.
Kalliope K
KK
Papadopoulou
School of Physical Sciences & Computing, Division of Chemistry, University of Central Lancashire, Preston PR1 2HE, United Kingdom.
Joseph M
JM
Hayes
Department of Biochemistry and Biotechnology, University of Thessaly, Larissa, Greece. Electronic address: ampsarra@bio.uth.gr.
Anna-Maria G
AG
Psarra
D021581:Active Transport, Cell Nucleus / Q000187:drug effects; D000818:Animals; D002460:Cell Line; D002467:Cell Nucleus / Q000187:drug effects / Q000378:metabolism; D005960:Glucosides / Q000737:chemistry*; D006801:Humans; D062105:Molecular Docking Simulation; D016328:NF-kappa B / Q000378:metabolism; D009828:Oleanolic Acid / Q000031:analogs & derivatives* / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D011487:Protein Conformation; D011965:Receptors, Glucocorticoid / Q000819:agonists* / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D015533:Transcriptional Activation / Q000187:drug effects
D005960:Glucosides; D016328:NF-kappa B; D011965:Receptors, Glucocorticoid; D009828:Oleanolic Acid; C022999:echinocystic acid
Apoptosis; Echinocystic acids; Glucocorticoid receptor; NF-κΒ; SEGRA